Infections with candidatus neoehrlichia mikurensis and cytokine responses in 2 persons bitten by ticks, Sweden

Emerging Infectious Diseases

Volumn 21, Issue 8, 2015, Pages 1462-1465

  Grankvist, Anna ^a,b   Sandelin, Lisa Labbé ^c,d   Andersson, Jennie ^a,b   Fryland, Linda ^e   Wilhelmsson, Peter ^e   Lindgren, Per Eric ^e,f   Forsberg, Pia ^e   Wennerås, Christine ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KALMAR COUNTY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e LINKÖPING UNIVERSITY   (Sweden)

^f RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PENICILLIN V; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; AGED; ANAPLASMA PHAGOCYTOPHILUM; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BORRELIA; CANDIDATUS NEOEHRLICHIA MIKURENSIS; CANDIDATUS NEOEHRLICHIA MIKURENSIS INFECTION; CASE REPORT; CROSS REACTION; CYTOKINE RESPONSE; ERYTHEMA; FEMALE; GENE DOSAGE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; MIDDLE AGED; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RICKETTSIALES; SEROCONVERSION; SWEDEN; TICK BITE; ANIMAL; CANDIDIASIS, CUTANEOUS; COMPLICATION; GENETICS; METABOLISM; MIXED INFECTION; PATHOLOGY; TICK; TICK-BORNE DISEASES;

AGED; ANIMALS; CANDIDIASIS, CUTANEOUS; COINFECTION; CYTOKINES; DNA, BACTERIAL; FEMALE; HUMANS; MIDDLE AGED; SWEDEN; TICK-BORNE DISEASES; TICKS;

EID: 84937439386     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2108.150060     Document Type: Article

References (15)

1. Wenneras C. Infections with the tick-borne bacterium Candidatus Neoehrlichia mikurensis. Clin Microbiol Infect. 2015 Mar 11:pii: S1198-743X(15)00324-9.
2. Grankvist A, Andersson PO, Mattsson M, Sender M, Vaht K, Hoper L, et al. Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases. Clin Infect Dis. 2014;58:1716-22. http://dx.doi.org/10.1093/cid/ciu189
3. Welc-Faleciak R, Sinski E, Kowalec M, Zajkowska J, Pancewicz SA. Asymptomatic "Candidatus Neoehrlichia mikurensis" infections in immunocompetent humans. J Clin Microbiol. 2014;52:3072-4. http://dx.doi.org/10.1128/JCM.00741-14
4. Fehr JS, Bloemberg GV, Ritter C, Hombach M, Luscher TF, Weber R, et al. Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis. Emerg Infect Dis. 2010;16:1127-9. http://dx.doi.org/10.3201/eid1607.091907
5. Li H, Jiang JF, Liu W, Zheng YC, Huo QB, Tang K, et al. Human infection with Candidatus Neoehrlichia mikurensis, China. Emerg Infect Dis. 2012;18:1636-9. http://dx.doi.org/10.3201/eid1810.120594
6. von Loewenich FD, Geissdorfer W, Disque C, Matten J, Schett G, Sakka SG, et al. Detection of "Candidatus Neoehrlichia mikurensis" in two patients with severe febrile illnesses: evidence for a European sequence variant. J Clin Microbiol. 2010;48:2630-5. http://dx.doi.org/10.1128/JCM.00588-10
7. Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME. Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Clin Vaccine Immunol. 2008;15:1519-22. http://dx.doi.org/10.1128/CVI.00109-08
8. Hammers-Berggren S, Lebech AM, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol. 1994;32:1519-25.
9. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. J Clin Microbiol. 1993;31:3090-5.
10. Sjöwall J, Fryland L, Nordberg M, Sjogren F, Garpmo U, Jansson C, et al. Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans. PLoS ONE. 2011;6:e18220. http://dx.doi.org/10.1371/journal.pone.0018220
11. Dumler JS, Dotevall L, Gustafson R, Granstrom M. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden. J Infect Dis. 1997;175:720-2. http://dx.doi.org/10.1093/infdis/175.3.720
12. Wittesjö B, Bjoersdorff A, Eliasson I, Berglund J. First long-term study of the seroresponse to the agent of human granulocytic ehrlichiosis among residents of a tick-endemic area of Sweden. Eur J Clin Microbiol Infect Dis. 2001;20:173-8. http://dx.doi.org/ 10.1007/s100960100463
13. Andersson M, Bartkova S, Lindestad O, Raberg L. Co-infection with 'Candidatus Neoehrlichia mikurensis' and Borrelia afzelii in Ixodes ricinus ticks in southern Sweden. Vector Borne Zoonotic Dis. 2013;13:438-42. http://dx.doi.org/10.1089/vbz.2012.1118
14. Salazar JC, Pope CD, Sellati TJ, Feder HM Jr, Kiely TG, Dardick KR, et al. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol. 2003;171:2660-70. http://dx.doi.org/10.4049/jimmunol.171.5.2660
15. Diniz PP, Schulz BS, Hartmann K, Breitschwerdt EB. "Candidatus Neoehrlichia mikurensis" infection in a dog from Germany. J Clin Microbiol. 2011;49:2059-62. http://dx.doi.org/10.1128/JCM.02327-10